Article info
Clinical science
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis
- Correspondence to Dr Elisabetta Miserocchi, Ocular Immunology and Uveitis Service, Department of Ophthalmology, Scientific Institute San Raffaele, University Vita-Salute, Via Olgettina 60, Milan 20132, Italy; miserocchi.elisabetta{at}hsr.it
Citation
Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis
Publication history
- Received February 19, 2015
- Revised May 20, 2015
- Accepted September 8, 2015
- First published September 22, 2015.
Online issue publication
February 22, 2018
Article Versions
- Previous version (20 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/